| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |